Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 15 |
NetGPI | no | yes: 0, no: 15 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 12 |
GO:0043226 | organelle | 2 | 16 |
GO:0043227 | membrane-bounded organelle | 3 | 16 |
GO:0043229 | intracellular organelle | 3 | 16 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 16 |
GO:0110165 | cellular anatomical entity | 1 | 16 |
Related structures:
AlphaFold database: E9AFY2
Term | Name | Level | Count |
---|---|---|---|
GO:0000966 | RNA 5'-end processing | 7 | 2 |
GO:0001682 | tRNA 5'-leader removal | 9 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 16 |
GO:0006396 | RNA processing | 6 | 16 |
GO:0006399 | tRNA metabolic process | 7 | 16 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 16 |
GO:0006807 | nitrogen compound metabolic process | 2 | 16 |
GO:0008033 | tRNA processing | 8 | 16 |
GO:0008152 | metabolic process | 1 | 16 |
GO:0009987 | cellular process | 1 | 16 |
GO:0016070 | RNA metabolic process | 5 | 16 |
GO:0034470 | ncRNA processing | 7 | 16 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 16 |
GO:0034660 | ncRNA metabolic process | 6 | 16 |
GO:0043170 | macromolecule metabolic process | 3 | 16 |
GO:0044237 | cellular metabolic process | 2 | 16 |
GO:0044238 | primary metabolic process | 2 | 16 |
GO:0046483 | heterocycle metabolic process | 3 | 16 |
GO:0071704 | organic substance metabolic process | 2 | 16 |
GO:0090304 | nucleic acid metabolic process | 4 | 16 |
GO:0099116 | tRNA 5'-end processing | 8 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 16 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 16 |
GO:0004518 | nuclease activity | 4 | 7 |
GO:0004519 | endonuclease activity | 5 | 6 |
GO:0004521 | RNA endonuclease activity | 5 | 6 |
GO:0004526 | ribonuclease P activity | 6 | 6 |
GO:0004540 | RNA nuclease activity | 4 | 6 |
GO:0004549 | tRNA-specific ribonuclease activity | 5 | 6 |
GO:0016787 | hydrolase activity | 2 | 16 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 7 |
GO:0016891 | RNA endonuclease activity, producing 5'-phosphomonoesters | 6 | 6 |
GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6 | 6 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 6 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 6 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 6 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 350 | 354 | PF00656 | 0.452 |
CLV_C14_Caspase3-7 | 368 | 372 | PF00656 | 0.526 |
CLV_C14_Caspase3-7 | 467 | 471 | PF00656 | 0.447 |
CLV_NRD_NRD_1 | 164 | 166 | PF00675 | 0.459 |
CLV_NRD_NRD_1 | 177 | 179 | PF00675 | 0.297 |
CLV_NRD_NRD_1 | 21 | 23 | PF00675 | 0.660 |
CLV_NRD_NRD_1 | 414 | 416 | PF00675 | 0.241 |
CLV_PCSK_FUR_1 | 19 | 23 | PF00082 | 0.715 |
CLV_PCSK_KEX2_1 | 164 | 166 | PF00082 | 0.454 |
CLV_PCSK_KEX2_1 | 176 | 178 | PF00082 | 0.329 |
CLV_PCSK_KEX2_1 | 18 | 20 | PF00082 | 0.678 |
CLV_PCSK_KEX2_1 | 21 | 23 | PF00082 | 0.643 |
CLV_PCSK_KEX2_1 | 414 | 416 | PF00082 | 0.257 |
CLV_PCSK_PC1ET2_1 | 176 | 178 | PF00082 | 0.428 |
CLV_PCSK_PC1ET2_1 | 18 | 20 | PF00082 | 0.728 |
CLV_PCSK_SKI1_1 | 164 | 168 | PF00082 | 0.450 |
CLV_PCSK_SKI1_1 | 177 | 181 | PF00082 | 0.265 |
CLV_PCSK_SKI1_1 | 263 | 267 | PF00082 | 0.475 |
CLV_PCSK_SKI1_1 | 296 | 300 | PF00082 | 0.478 |
CLV_PCSK_SKI1_1 | 306 | 310 | PF00082 | 0.431 |
CLV_PCSK_SKI1_1 | 370 | 374 | PF00082 | 0.380 |
CLV_PCSK_SKI1_1 | 512 | 516 | PF00082 | 0.381 |
CLV_PCSK_SKI1_1 | 58 | 62 | PF00082 | 0.441 |
CLV_Separin_Metazoa | 217 | 221 | PF03568 | 0.412 |
CLV_Separin_Metazoa | 95 | 99 | PF03568 | 0.505 |
DEG_APCC_DBOX_1 | 163 | 171 | PF00400 | 0.499 |
DOC_CKS1_1 | 109 | 114 | PF01111 | 0.516 |
DOC_CKS1_1 | 430 | 435 | PF01111 | 0.330 |
DOC_CYCLIN_RxL_1 | 260 | 269 | PF00134 | 0.500 |
DOC_CYCLIN_yCln2_LP_2 | 449 | 455 | PF00134 | 0.373 |
DOC_MAPK_DCC_7 | 389 | 398 | PF00069 | 0.596 |
DOC_MAPK_gen_1 | 176 | 185 | PF00069 | 0.444 |
DOC_MAPK_gen_1 | 414 | 423 | PF00069 | 0.323 |
DOC_MAPK_gen_1 | 509 | 518 | PF00069 | 0.436 |
DOC_MAPK_HePTP_8 | 185 | 197 | PF00069 | 0.410 |
DOC_MAPK_MEF2A_6 | 143 | 151 | PF00069 | 0.380 |
DOC_MAPK_MEF2A_6 | 188 | 197 | PF00069 | 0.417 |
DOC_MAPK_MEF2A_6 | 512 | 520 | PF00069 | 0.452 |
DOC_MAPK_MEF2A_6 | 78 | 85 | PF00069 | 0.508 |
DOC_PP4_FxxP_1 | 390 | 393 | PF00568 | 0.639 |
DOC_SPAK_OSR1_1 | 389 | 393 | PF12202 | 0.624 |
DOC_SPAK_OSR1_1 | 490 | 494 | PF12202 | 0.442 |
DOC_USP7_MATH_1 | 2 | 6 | PF00917 | 0.762 |
DOC_USP7_MATH_1 | 30 | 34 | PF00917 | 0.508 |
DOC_USP7_MATH_1 | 344 | 348 | PF00917 | 0.538 |
DOC_WW_Pin1_4 | 108 | 113 | PF00397 | 0.496 |
DOC_WW_Pin1_4 | 289 | 294 | PF00397 | 0.585 |
DOC_WW_Pin1_4 | 429 | 434 | PF00397 | 0.376 |
DOC_WW_Pin1_4 | 448 | 453 | PF00397 | 0.354 |
LIG_14-3-3_CanoR_1 | 389 | 393 | PF00244 | 0.637 |
LIG_14-3-3_CanoR_1 | 498 | 504 | PF00244 | 0.391 |
LIG_14-3-3_CanoR_1 | 512 | 517 | PF00244 | 0.368 |
LIG_14-3-3_CanoR_1 | 522 | 527 | PF00244 | 0.351 |
LIG_14-3-3_CanoR_1 | 6 | 15 | PF00244 | 0.721 |
LIG_Actin_WH2_2 | 137 | 152 | PF00022 | 0.458 |
LIG_BIR_III_2 | 168 | 172 | PF00653 | 0.486 |
LIG_BIR_III_4 | 66 | 70 | PF00653 | 0.507 |
LIG_BRCT_BRCA1_1 | 390 | 394 | PF00533 | 0.614 |
LIG_BRCT_BRCA1_1 | 450 | 454 | PF00533 | 0.426 |
LIG_Clathr_ClatBox_1 | 137 | 141 | PF01394 | 0.245 |
LIG_FHA_1 | 109 | 115 | PF00498 | 0.526 |
LIG_FHA_1 | 238 | 244 | PF00498 | 0.531 |
LIG_FHA_1 | 513 | 519 | PF00498 | 0.362 |
LIG_FHA_1 | 573 | 579 | PF00498 | 0.547 |
LIG_FHA_2 | 230 | 236 | PF00498 | 0.550 |
LIG_FHA_2 | 348 | 354 | PF00498 | 0.432 |
LIG_FHA_2 | 408 | 414 | PF00498 | 0.453 |
LIG_FHA_2 | 465 | 471 | PF00498 | 0.367 |
LIG_FHA_2 | 558 | 564 | PF00498 | 0.596 |
LIG_GBD_Chelix_1 | 299 | 307 | PF00786 | 0.536 |
LIG_LIR_Apic_2 | 108 | 112 | PF02991 | 0.296 |
LIG_LIR_Apic_2 | 388 | 393 | PF02991 | 0.622 |
LIG_LIR_Gen_1 | 212 | 223 | PF02991 | 0.338 |
LIG_LIR_Gen_1 | 335 | 344 | PF02991 | 0.444 |
LIG_LIR_Gen_1 | 347 | 355 | PF02991 | 0.407 |
LIG_LIR_Gen_1 | 457 | 466 | PF02991 | 0.366 |
LIG_LIR_Gen_1 | 481 | 492 | PF02991 | 0.343 |
LIG_LIR_Nem_3 | 212 | 218 | PF02991 | 0.370 |
LIG_LIR_Nem_3 | 335 | 339 | PF02991 | 0.400 |
LIG_LIR_Nem_3 | 347 | 351 | PF02991 | 0.400 |
LIG_LIR_Nem_3 | 457 | 462 | PF02991 | 0.354 |
LIG_LIR_Nem_3 | 481 | 487 | PF02991 | 0.310 |
LIG_LIR_Nem_3 | 502 | 506 | PF02991 | 0.387 |
LIG_MAD2 | 104 | 112 | PF02301 | 0.489 |
LIG_PCNA_yPIPBox_3 | 92 | 106 | PF02747 | 0.506 |
LIG_Pex14_1 | 211 | 215 | PF04695 | 0.406 |
LIG_Pex14_1 | 539 | 543 | PF04695 | 0.426 |
LIG_Pex14_2 | 136 | 140 | PF04695 | 0.474 |
LIG_Pex14_2 | 180 | 184 | PF04695 | 0.381 |
LIG_Pex14_2 | 390 | 394 | PF04695 | 0.637 |
LIG_Pex14_2 | 491 | 495 | PF04695 | 0.385 |
LIG_PTB_Apo_2 | 453 | 460 | PF02174 | 0.354 |
LIG_PTB_Apo_2 | 59 | 66 | PF02174 | 0.379 |
LIG_PTB_Phospho_1 | 453 | 459 | PF10480 | 0.354 |
LIG_REV1ctd_RIR_1 | 489 | 498 | PF16727 | 0.385 |
LIG_SH2_CRK | 348 | 352 | PF00017 | 0.409 |
LIG_SH2_CRK | 463 | 467 | PF00017 | 0.365 |
LIG_SH2_CRK | 503 | 507 | PF00017 | 0.383 |
LIG_SH2_STAP1 | 348 | 352 | PF00017 | 0.409 |
LIG_SH2_STAP1 | 438 | 442 | PF00017 | 0.417 |
LIG_SH2_STAP1 | 524 | 528 | PF00017 | 0.341 |
LIG_SH2_STAT5 | 107 | 110 | PF00017 | 0.404 |
LIG_SH2_STAT5 | 366 | 369 | PF00017 | 0.554 |
LIG_SH2_STAT5 | 459 | 462 | PF00017 | 0.330 |
LIG_SH2_STAT5 | 483 | 486 | PF00017 | 0.461 |
LIG_SH2_STAT5 | 543 | 546 | PF00017 | 0.452 |
LIG_SH3_3 | 176 | 182 | PF00018 | 0.468 |
LIG_SH3_3 | 389 | 395 | PF00018 | 0.526 |
LIG_SH3_3 | 483 | 489 | PF00018 | 0.471 |
LIG_SH3_4 | 309 | 316 | PF00018 | 0.597 |
LIG_SUMO_SIM_anti_2 | 546 | 551 | PF11976 | 0.531 |
LIG_TRFH_1 | 289 | 293 | PF08558 | 0.432 |
LIG_TYR_ITIM | 357 | 362 | PF00017 | 0.404 |
LIG_TYR_ITIM | 501 | 506 | PF00017 | 0.383 |
LIG_WRC_WIRS_1 | 286 | 291 | PF05994 | 0.463 |
MOD_CDK_SPK_2 | 108 | 113 | PF00069 | 0.414 |
MOD_CDK_SPxxK_3 | 289 | 296 | PF00069 | 0.430 |
MOD_CK1_1 | 325 | 331 | PF00069 | 0.564 |
MOD_CK1_1 | 33 | 39 | PF00069 | 0.438 |
MOD_CK1_1 | 347 | 353 | PF00069 | 0.526 |
MOD_CK1_1 | 364 | 370 | PF00069 | 0.455 |
MOD_CK1_1 | 383 | 389 | PF00069 | 0.622 |
MOD_CK1_1 | 7 | 13 | PF00069 | 0.769 |
MOD_CK2_1 | 229 | 235 | PF00069 | 0.562 |
MOD_CK2_1 | 313 | 319 | PF00069 | 0.581 |
MOD_CK2_1 | 400 | 406 | PF00069 | 0.511 |
MOD_CK2_1 | 407 | 413 | PF00069 | 0.424 |
MOD_Cter_Amidation | 415 | 418 | PF01082 | 0.385 |
MOD_GlcNHglycan | 116 | 119 | PF01048 | 0.465 |
MOD_GlcNHglycan | 27 | 31 | PF01048 | 0.577 |
MOD_GlcNHglycan | 385 | 388 | PF01048 | 0.607 |
MOD_GlcNHglycan | 509 | 512 | PF01048 | 0.242 |
MOD_GlcNHglycan | 560 | 563 | PF01048 | 0.609 |
MOD_GSK3_1 | 26 | 33 | PF00069 | 0.547 |
MOD_GSK3_1 | 285 | 292 | PF00069 | 0.467 |
MOD_GSK3_1 | 379 | 386 | PF00069 | 0.577 |
MOD_GSK3_1 | 464 | 471 | PF00069 | 0.398 |
MOD_GSK3_1 | 554 | 561 | PF00069 | 0.596 |
MOD_GSK3_1 | 577 | 584 | PF00069 | 0.569 |
MOD_N-GLC_1 | 434 | 439 | PF02516 | 0.393 |
MOD_N-GLC_1 | 507 | 512 | PF02516 | 0.443 |
MOD_N-GLC_1 | 554 | 559 | PF02516 | 0.661 |
MOD_NEK2_1 | 114 | 119 | PF00069 | 0.476 |
MOD_NEK2_1 | 125 | 130 | PF00069 | 0.424 |
MOD_NEK2_1 | 266 | 271 | PF00069 | 0.538 |
MOD_NEK2_1 | 373 | 378 | PF00069 | 0.537 |
MOD_NEK2_1 | 4 | 9 | PF00069 | 0.767 |
MOD_PIKK_1 | 532 | 538 | PF00454 | 0.464 |
MOD_PK_1 | 522 | 528 | PF00069 | 0.404 |
MOD_PKA_2 | 388 | 394 | PF00069 | 0.636 |
MOD_PKA_2 | 499 | 505 | PF00069 | 0.397 |
MOD_Plk_1 | 325 | 331 | PF00069 | 0.592 |
MOD_Plk_1 | 434 | 440 | PF00069 | 0.437 |
MOD_Plk_1 | 554 | 560 | PF00069 | 0.663 |
MOD_Plk_4 | 347 | 353 | PF00069 | 0.445 |
MOD_Plk_4 | 361 | 367 | PF00069 | 0.383 |
MOD_Plk_4 | 37 | 43 | PF00069 | 0.538 |
MOD_Plk_4 | 522 | 528 | PF00069 | 0.380 |
MOD_Plk_4 | 554 | 560 | PF00069 | 0.586 |
MOD_Plk_4 | 81 | 87 | PF00069 | 0.425 |
MOD_ProDKin_1 | 108 | 114 | PF00069 | 0.488 |
MOD_ProDKin_1 | 289 | 295 | PF00069 | 0.583 |
MOD_ProDKin_1 | 429 | 435 | PF00069 | 0.376 |
MOD_ProDKin_1 | 448 | 454 | PF00069 | 0.354 |
MOD_SUMO_rev_2 | 33 | 41 | PF00179 | 0.460 |
MOD_SUMO_rev_2 | 335 | 342 | PF00179 | 0.532 |
MOD_SUMO_rev_2 | 364 | 372 | PF00179 | 0.459 |
TRG_DiLeu_BaEn_1 | 238 | 243 | PF01217 | 0.543 |
TRG_DiLeu_BaEn_1 | 37 | 42 | PF01217 | 0.541 |
TRG_ENDOCYTIC_2 | 215 | 218 | PF00928 | 0.348 |
TRG_ENDOCYTIC_2 | 348 | 351 | PF00928 | 0.382 |
TRG_ENDOCYTIC_2 | 359 | 362 | PF00928 | 0.386 |
TRG_ENDOCYTIC_2 | 459 | 462 | PF00928 | 0.318 |
TRG_ENDOCYTIC_2 | 463 | 466 | PF00928 | 0.302 |
TRG_ENDOCYTIC_2 | 483 | 486 | PF00928 | 0.461 |
TRG_ENDOCYTIC_2 | 503 | 506 | PF00928 | 0.133 |
TRG_ER_diArg_1 | 163 | 165 | PF00400 | 0.442 |
TRG_ER_diArg_1 | 177 | 179 | PF00400 | 0.264 |
TRG_ER_diArg_1 | 19 | 22 | PF00400 | 0.647 |
TRG_ER_diArg_1 | 374 | 377 | PF00400 | 0.502 |
TRG_ER_diArg_1 | 495 | 498 | PF00400 | 0.324 |
TRG_NES_CRM1_1 | 59 | 74 | PF08389 | 0.298 |
TRG_NLS_Bipartite_1 | 164 | 180 | PF00514 | 0.503 |
TRG_NLS_MonoCore_2 | 17 | 22 | PF00514 | 0.746 |
TRG_NLS_MonoExtC_3 | 17 | 22 | PF00514 | 0.737 |
TRG_NLS_MonoExtN_4 | 15 | 22 | PF00514 | 0.741 |
TRG_Pf-PMV_PEXEL_1 | 164 | 168 | PF00026 | 0.493 |
TRG_Pf-PMV_PEXEL_1 | 426 | 430 | PF00026 | 0.330 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I198 | Leptomonas seymouri | 67% | 99% |
A0A0S4JLM5 | Bodo saltans | 39% | 100% |
A0A1X0P3X4 | Trypanosomatidae | 32% | 100% |
A0A1X0P680 | Trypanosomatidae | 42% | 100% |
A0A3Q8IIJ5 | Leishmania donovani | 94% | 100% |
A0A3R7LTW4 | Trypanosoma rangeli | 45% | 100% |
A0A422MWI6 | Trypanosoma rangeli | 30% | 100% |
A4HNH1 | Leishmania braziliensis | 82% | 100% |
A4IC62 | Leishmania infantum | 94% | 100% |
C9ZYE1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
D0A6B5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 100% |
E9B735 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
V5B8T9 | Trypanosoma cruzi | 44% | 100% |
V5BPA7 | Trypanosoma cruzi | 30% | 100% |